RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE Vazkepa® supported by strong clinical data package and expected to contribute to Specialty & Primary Care growth in coming years Milan, 24 June 2025 – Recordati today announced a licensing and supply agreement with Amarin to commercialize the marketed cardiovascular medicine, Vazkepa® (icosapent ethyl) across 59 countries, focused in Europe. Vazkepa® is indicated to reduce the risk of cardiovascular ev ...

Up to $1.25 billion ($250 million upfront) of synthetic royalty funding and up to $750 million in secured debt Innovative partnership enables Revolution Medicines to retain control over pipeline development and global commercialization of daraxonrasib Highlights Royalty Pharma’s unique ability to provide capital at scale to help leading companies achieve their strategic goalsDaraxonrasib, in Phase 3 development for pancreatic cancer and non-small cell lung cancer, would be the first targeted therapy to inhi ...

ALBUQUERQUE, N.M., June 24, 2025 (GLOBE NEWSWIRE) -- Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “ARRAY”) today announced that, subject to market conditions, it intends to offer $250 million in aggregate principal amount of convertible senior notes due 2031 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). ARRAY also intends to grant th ...

Core Insights - Calian Group Ltd. has appointed Chris Pogue as President of Defence & Space, effective July 7, 2025, to lead a newly created organization that integrates its Advanced Technologies and Learning business units [1][2] - Pogue brings over 20 years of experience in defence and space innovation, having previously served as President and CEO of Thales Canada and held leadership roles at MDA Government and General Dynamics [2] - The appointment aligns with Calian's One Calian 2026 strategy, enhancing its capability to deliver mission-critical solutions amid growing global demand [3] Company Overview - Calian Group Ltd. focuses on mission-critical solutions in defence, space, healthcare, and strategic growth critical infrastructure sectors [1] - The company has a 40-year history and operates in North American, European, and international markets, emphasizing values such as customer commitment, integrity, innovation, respect, and teamwork [4]

Firmware over-the-air updates and remote cryptographic key management provide scalable solutions for addressing IoT security challengesCHANDLER, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- International cybersecurity regulations continue to adapt to meet the evolving threat landscape. One major focus is on outdated firmware in IoT devices, which can present significant security vulnerabilities. To address these challenges, Microchip Technology (Nasdaq: MCHP) is enhancing its TrustMANAGER platform to include se ...

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) ("RWB" or the "Company") announces that its Annual General Meeting ("AGM"), originally scheduled for Friday, June 27, 2025, has been rescheduled to Friday, July 11, 2025. The change will allow for the completion and filing of the Company's audited financial statements and accompanying management discussion and analysis for the year-ended December 31, 2024, both of which will be presented at the AGM. The change to the annual ...

C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class Profile with Short Treatment Duration, Low Risk for Drug-Drug Interactions and Convenience with No Food Effect HCV Infection Remains a Significant Global Health Burden, with Approximately 50 Million People Infected, Including up to 4 Million in US BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, ...

-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- Dr. Kostas continued, "We are pleased to place VAZKEPA, a drug with proven, meaningful cardiovascular benefit when added to statins, in the hands of a partner with the capabilities and experience in the cardiovascular space in Europe as Recordati. We believe this partnership for VAZKEPA positions both companies to benefit from future sales growt ...

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- STORAGEVAULT CANADA INC. ("StorageVault") (SVI-TSX) is pleased to announce that, further to its April 23, 2025 news release, it has completed the acquisition of seven stores and one adjacent vacant parcel of land (collectively, the "Acquisitions") from six vendor groups (collectively, the "Vendors"), for an aggregate purchase price of $71.9 million. Six of the Acquisitions are arm's length and two, totaling $21.9 million, are related party acquisitions (the "Relate ...

IRVINE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that Lantronix has been named the 2025 Industrial IoT Company of the Year by CompassIntel, a leading market research and advisory firm specializing in metrics-driven market intelligence and insights for the mobile, IoT and high-tech industries. The 13 annual CompassIntel Awards honor companies, vendors and organizations ...